A total of 143 group B streptococcus (GBS) isolates collected from mothers at the Maternity Hospital in Kuwait were investigated for their serotypes and antibiotic resistance, and screened by PCR for the carriage of genes for resistance to tetracycline (tetk, tetM, tetL, tetO), erythromycin (ermA, ermB, ermC, ermTR, ermM, mefA, mefE, msrA) and aminoglycosides (aph3, ant4, ant6). All isolates were serotyped using a latex agglutination test. Most of the isolates belonged to serotypes V (38.5 %), III (20.9 %), Ia (7.7 %) and II (11.2 %). Sixteen isolates (11.2 %) were nontypable. All isolates were susceptible to penicillin, ampicillin and cefotaxime (MICs 0.016–0.094 µg ml−1) but were resistant to trimethoprim (92.3 %), tetracycline (89.5 %), minocycline (89.5 %), high-level kanamycin (76.9 %), chloramphenicol (30.0 %), erythromycin (12.6 %), clindamycin (7.0 %), high-level streptomycin (3.5 %) and ciprofloxacin (0.7 %). The tetracycline-resistant isolates contained tetM (94.5 %), tetO (3.9 %), tetL (1.6 %) and tetK (0.8 %). The erythromycin-resistant isolates contained ermB (61.1 %), ermTR (38.9 %), ermA (5.5 %), mefA (5.5 %) and mefE (11 %). All high-level kanamycin-resistant isolates contained aph3. One of the high-level streptomycin-resistant isolates contained ant6. Partial DNA sequencing of aph3 revealed sequences with 99 % similarity to aph3 found in Enterococcus faecium, Enterococcus faecalis, Staphylococcus aureus and Staphylococcus epidermidis, suggesting that the GBS isolates could have acquired aph3 from other Gram-positive cocci. The high proportion of isolates with resistance to tetracycline, high-level kanamycin and trimethoprim, and the increase in the prevalence of erythromycin resistance, represents an emerging public health concern that needs further surveillance.
AcikgozZ. C.,
AlmayanlarE.,
GamberzadeS.,
GocerS.2004; Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital. Antimicrob Agents Chemother 48:1410–1412 [View Article][PubMed]
Al-SweihN.,
JamalM.,
KurdiaM.,
AbduljabarR.,
RotimiV.2005b; Antibiotic susceptibility profile of group B streptococcus (Streptococcus agalactiae) at the maternity hospital, Kuwait. Med Princ Pract 14:260–263 [View Article][PubMed]
AminA.,
AbdulrazzaqY. M.,
UdumanS.2002; Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates. J Infect 45:42–46 [View Article][PubMed]
AracilB.,
MiñambresM.,
OteoJ.,
De La RosaM.,
Gómez-GarcésJ. L.,
AlósA. J.2002; Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes. Clin Microbiol Infect 8:745–748 [View Article][PubMed]
BensonJ. A.,
FerrieriP.2001; Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates. J Clin Microbiol 39:3006–3008 [View Article][PubMed]
BiedenbachD. J.,
TolemanM. A.,
WalshT. R.,
JonesR. N.2006; Characterization of fluoroquinolone-resistant β-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997–2004). Diagn Microbiol Infect Dis 55:119–127 [View Article][PubMed]
BrimilN.,
BarthellE.,
HeindrichsU.,
KuhnM.,
LüttickenR.,
SpellerbergB.2006; Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med Microbiol 296:39–44 [View Article][PubMed]
CastorM. L.,
WhitneyC. G.,
Como-SabettiK.,
FacklamR. R.,
FerrieriP.,
BartkusJ. M.,
JuniB. A.,
CieslakP. R.,
FarleyM. M.other authors2008; Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecolhttp://dx.doi.org/10.1155/2008/727505 (Epub ahead of print) [PubMed]
ChuY. W.,
TseC.,
TsangG. K. L.,
SoD. K. S.,
FungJ. T. L.,
LoJ. Y. C.2007; Invasive group B Streptococcus isolates showing reduced susceptibility to penicillin in Hong Kong. J Antimicrob Chemother 60:1407–1409 [View Article][PubMed]
CLSI2005; Performance Standards for Antimicrobial Susceptibility Testing, 15th supplement, M100–S15. Wayne, PA: Clinical and Laboratory Standards Institute;
DaheshS.,
HenslerM. E.,
Van SorgeN. M.,
GertzR. E.Jr,
SchragS.,
NizetV.,
BeallB. W.2008; Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to β-lactam antibiotics. Antimicrob Agents Chemother 52:2915–2918 [View Article][PubMed]
de AzavedoJ. C. S.,
McGavinM.,
DuncanC.,
LowD. E.,
McGeerA.2001; Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45:3504–3508 [View Article][PubMed]
De MouyD.,
CavalloJ.-D.,
LeclercqR.,
FabreR.The Aforcopi-Bio Network2001; Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob Agents Chemother 45:2400–2402 [View Article][PubMed]
DiekemaD. J.,
AndrewsJ. I.,
HuynhH.,
RhombergP. R.,
DoktorS. R.,
BeyerJ.,
ShortridgeV. D.,
FlammR. K.,
JonesR. N.,
PfallerM. A.2003; Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol 41:2659–2661 [View Article][PubMed]
DoganB.,
SchukkenY. H.,
SantistebanC.,
BoorK. J.2005; Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts. J Clin Microbiol 43:5899–5906 [View Article][PubMed]
DuarteR. S.,
BelleiB. C.,
MirandaO. P.,
BritoM. A. V. P.,
TeixeiraL. M.2005; Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Antimicrob Agents Chemother 49:97–103 [View Article][PubMed]
Figueira-CoelhoJ.,
RamirezM.,
SalgadoM. J.,
Melo-CristinoJ.2004; Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb Drug Resist 10:31–36 [View Article][PubMed]
HarrisonL. H.,
ElliottJ. A.,
DwyerD. M.,
LibonatiJ. P.,
FerrieriP.,
BillmannL.,
SchuchatA.1998; Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis 177:998–1002[PubMed][CrossRef]
HsuehP. R.,
TengL. J.,
LeeL. N.,
HoS. W.,
YangP. C.,
LuhK. T.2001; High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 45:3205–3208 [View Article][PubMed]
LachenauerC. S.,
KasperD. L.,
ShimadaJ.,
IchimanY.,
OhtsukaH.,
KakuM.,
PaolettiL. C.,
FerrieriP.,
MadoffL. C.1999; Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 179:1030–1033 [View Article][PubMed]
LopardoH. A.,
VidalP.,
JericP.,
CentronD.,
PaganiniH.,
FacklamR. R.The Argentinian Streptococcus Study GroupElliottJ.2003; Six-month multicenter study on invasive infections due to group B streptococci in Argentina. J Clin Microbiol 41:4688–4694 [View Article][PubMed]
MansouriS.,
GhasamiE.,
Shahabi NajadN.2008; Vaginal colonization of group B streptococci during late pregnancy in southeast of Iran: incidence, serotype distribution and susceptibility to antibiotics. J Med Sci 8:574–578 [View Article]
NishimotoY.,
KobayashiN.,
AlamM. M.,
IshinoM.,
UeharaN.,
WatanabeN.2005; Analysis of the prevalence of tetracycline resistance genes in clinical isolates of Enterococcus faecalis and Enterococcus faecium in a Japanese hospital. Microb Drug Resist 11:146–153 [View Article][PubMed]
PerssonE.,
BergS.,
TrollforsB.,
LarssonP.,
EkE.,
BackhausE.,
ClaessonB. E.,
JonssonL.,
RådbergG.other authors2004; Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998–2001. Clin Microbiol Infect 10:791–796 [View Article][PubMed]
PoyartC.,
JardyL.,
QuesneG.,
BercheP.,
Trieu-CuotP.2003; Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 47:794–797 [View Article][PubMed]
PylipowM.,
GaddisM.,
KinneyJ. S.1994; Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. Pediatrics 93:631–635
RubensC. E.,
WesselsM. R.,
HeggenL. M.,
KasperD. L.1987; Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A 84:7208–7212 [View Article][PubMed]
TenoverF. C.,
ArbeitR. D.,
GoeringR. V.,
MickelsenP. A.,
MurrayB. E.,
PersingD. H.,
SwaminathanB.1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239[PubMed]
UdoE. E.,
Al-SweihN.,
JohnP.,
JacobL. E.,
MohanakrishnanS.2004; Characterization of high-level aminoglycoside-resistant enterococci in Kuwait hospitals. Microb Drug Resist 10:139–145 [View Article][PubMed]
VictorN.,
RubensC. E.2000; Pathogenic mechanisms and virulence factors of group B streptococci. In Gram-positive Pathogens pp. 125–136 Edited by
FischettiV. A.,
NovickR. P.,
FerrettiJ. J.,
PortnoyD. A.,
RoodJ. I.
Washington, DC: ASM Press;
WuH. M.,
JanapatlaR. P.,
HoY. R.,
HungK. H.,
WuC. W.,
YanJ. J.,
WuJ. J.2008; Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan. Antimicrob Agents Chemother 52:1888–1890 [View Article][PubMed]
ZengX.,
KongF.,
WangH.,
DarbarA.,
GilbertG. L.2006; Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrob Agents Chemother 50:204–209 [View Article][PubMed]
ZhaoZ.,
KongF.,
ZengX.,
GiddingH. F.,
MorganJ.,
GilbertG. L.2008; Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups. Clin Microbiol Infect 14:260–267 [View Article][PubMed]